this is hero image

Getting Eversense 365 is simple

There are just three easy steps between you and the world's first and only ONE YEAR CGM.

Three easy steps. One brief office visit per year.

What to expect at the sensor placement appointment

Wondering how the Eversense 365 sensor gets in your arm? Click to see how simple the sensor placement is.

this is 50 | 50 image
Mary

“When I first came across Eversense, I took it to my Endocrinologist. It’s what I needed and what I knew would work for me.”

PLAY VIDEO
Chris

“It’s such a subtle process that it’s not something I really have to stress about. They place the sensor, link it—and I’m good to go for the entire year. I feel it’s such a simple process.”

PLAY VIDEO
Trevor

“It’s such a subtle process that it’s not something I really have to stress about. They place the sensor, link it—and I’m good to go for the entire year. I feel it’s such a simple process.”

PLAY VIDEO
Eversense glucose CGM user smiling, standing outside in a forest, wearing her device on arm

See why people are choosing
Eversense 365.

Learn more about the experiences of Eversense users whose lives were changed after switching to a long-term CGM.

Want to see if you
qualify?

Take our quick and easy quiz to see if Eversense 365 could work for you.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0047